MarketScreener Strategies Gilead Sciences, Inc.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2025-12-16 EST			5-day change	1st Jan Change
118.78 ^USD	-0.83%		-0.49%	+28.59%

12-15	RedHill Biopharma Ltd.'s Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells	CI
12-15	Gilead HIV combo of bictegravir & lenacapavir hits phase 3 goal	RE

No results for this search

Time To Grow PFL Fanbase, Revenue: CEO John Martin

July 11, 2025 at 04:09 am